STANOZOLOL TABS Cygnus

£31.00

Stanozolol tablets represent an extensively researched anabolic-androgenic steroid compound available for controlled laboratory investigations into steroid biochemistry and receptor binding mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
STANOZOLOL TABS Cygnus
STANOZOLOL TABS Cygnus
£31.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

STANOZOLOL TABS Cygnus at a Glance

Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone, distinguished by its unique structural modifications including a pyrazole ring attachment. This oral formulation allows researchers at Stroid UK Shop to investigate the compound’s pharmacokinetic properties and metabolic pathways in laboratory environments. Originally developed in the 1960s, stanozolol has become a significant reference compound in steroid research, offering valuable insights into anabolic mechanisms and tissue-selective effects. The compound demonstrates reduced androgenic activity compared to testosterone while maintaining substantial anabolic properties, making it particularly valuable for comparative studies examining steroid receptor selectivity and metabolic outcomes.

Laboratory Research Applications

Research teams utilise stanozolol tablets to examine protein synthesis pathways, nitrogen retention mechanisms, and collagen production in cellular models. The compound’s oral bioavailability makes it suitable for investigating hepatic metabolism and first-pass effects in pharmacokinetic studies. Comparative research often examines stanozolol alongside compounds from our oral steroids collection to evaluate relative potency and receptor binding affinities. Additionally, researchers explore the compound’s effects on fibrinolytic activity and plasma protein modulation. Modern laboratories frequently incorporate stanozolol investigations alongside SARM compounds and peptide research to develop comprehensive understanding of anabolic mechanisms and tissue-specific responses in controlled experimental settings.

Technical Specifications

Stanozolol Tablet Research Specifications
Parameter Value
CAS Number 10418-03-8
Molecular Formula C₂₁H₃₂N₂O
Molecular Weight 328.49 g/mol
Form Oral tablets
Storage Room temperature, dry environment
Stability Stable under proper storage conditions

Research Compliance Statement

This stanozolol tablet formulation is supplied exclusively for in-vitro research purposes and laboratory investigations. The compound is not intended for human consumption, clinical applications, or therapeutic use. Researchers must maintain appropriate laboratory protocols, safety measures, and regulatory compliance when handling this material. All investigations should be conducted within authorised research facilities by qualified personnel familiar with anabolic steroid handling procedures and safety requirements.

Related